Skip to content

Mark A. Lowry, MD

NPI 1386345197ActiveIndividual· Pathology, Anatomic Pathology & Clinical Pathology· Bethesda, MD

Pathology, Anatomic Pathology & Clinical Pathology (MD) in Bethesda, Maryland, licensed in MD, with an NPI issued in March 2023. Takeda Pharmaceuticals U.S.A., Inc. reported $35,922 in payments in 2025, mostly consulting fees.

Overview

NPI1386345197
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedMar 17, 2023
Last updated in NPPESMar 17, 2023
Certified by providerMar 17, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Pathology, Anatomic Pathology & Clinical Pathology Primary207ZP0102XMD-26920MD

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$35,922 · 12 payments from 1 company
  • 2024$34,320 · 12 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Takeda Pharmaceuticals U.S.A., Inc.$35,92212

What the 2025 payments were for

  • Consulting Fee$35,922 · 12 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other pathologists in Bethesda

All 51 pathologists in Bethesda · All pathologists in Maryland